FR Schuster, B Hubner, M Führer… - Blood Cancer …, 2011 - nature.com One of the major obstacles of immunosuppressive therapy (IST) in children with severe aplastic anemia (SAA) comes from the often months-long unpredictability of bone-marrow (BM) recovery. In this prospective study in children with newly diagnosed very severe AA ... Related articles
E Bousquet, S Camelo, G Leroux les Jardins… - … Ophthalmology & Visual …, 2011 - ARVO ... Protective effect of intravitreal administration of Tresperimus, an immunosuppressivedrug, on experimental autoimmune uveoretinitis ... Tresperimus is an immunosuppressivedrug structurally related to deoxyspergualin (DSG), which was initially developed as an antitumor agent. ... Related articles - All 2 versions
[PDF] from jofamericanscience.orgME Helal… - Journal of American Science, 2011 - jofamericanscience.org Abstract: Sirolimus is a modern immunosuppressive drug that has a novel mechanism of action as it improves the patients' condition receiving transplant. This study aimed to asses the effects of sirolimus Vs cyclosporin A (CsA) immunosuppressive drug on teeth's alveolar bone. ... Related articles - View as HTML
A Bernthaler, K Mönks, I Mühlberger… - Molecular …, 2011 - pubs.rsc.org Next to development of novel drugs also drug repositioning appears promising for tackling unmet clinical needs. Here Omics provided the ground for novel analysis strategies for linking drug and disease by integrating profiles on the molecular as well as the clinical data level. We ...
J Hester, N Mills, S Shankar… - …, 2011 - journals.lww.com ... Although advances in immunosuppressivedrug regimens over the last decades have led to significant improvement in 1-year transplant outcome ( 1 ), managing subclinical destructive processes leading to graft dysfunction and chronic rejection remains a major clinical ... Cited by 2 - Related articles - All 4 versions